Advertisement

Topics

Pancreatic cancer patients in England get CDF access to Abraxane

04:29 EDT 4 Aug 2017 | PharmaTimes

Patients with pancreatic cancer living in England can from today potentially get access to a new treatment option after funding for Celgene’s Abraxane was approved for NHS use.

Original Article: Pancreatic cancer patients in England get CDF access to Abraxane

NEXT ARTICLE

More From BioPortfolio on "Pancreatic cancer patients in England get CDF access to Abraxane"

Quick Search
Advertisement
 

Relevant Topics

Pancreatic Cancer
The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secrete hormones; Insulinoma, Gastrinoma, Somatostatinoma, VI...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...